Default company panoramic image
Logo

SynerZ Medical, Inc.

Outpatient, endoscopically delivered/removed anchorless device that mimics gastric bypass surgery for the treatment of obesity and type 2 diabetes.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location St. Louis, MO, USA
  • Currency USD
  • Founded June 2013
  • Employees 2

Company Summary

Clinical stage ready medical device company for the treatment of obesity and type 2 diabetes. Proprietary, stent-like, endoscopically delivered device that mimics the MOA of gastric bypass surgery for the treatment of obesity and type-II diabetes. 500 million obese patients worldwide, 84 million type 2 diabetes patients, offers patients, providers, payors a simpler, safer, significantly less invasive and cost-effective alternative to surgery.

Team

  • Default avatar
    James R Bachman
    President

    *Barclays Capital (formerly known as Lehman Brothers) healthcare investment banking - executed mergers and acquisitions, debt and equity financing transactions totaling over $5.1bn
    *Piper Jaffray - healthcare investment banking; transactions totaling over $375mm.
    *Deloitte Financial Advisory Services
    *Andersen Consulting
    *B.A., Biology, Saint Louis University *M.B.A., Olin School of Business, Washington University in St. Louis

Advisors

  • Default avatar
    Bryan Cave LLP
    Lawyer
    Unconfirmed